|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | |
| A61K 45/06 | |||
| A61P 25/08 | |||
| A61K 9/00 | |||
| A61K 9/08 |
| (11) | Number of the document | 3160457 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15733514.2 |
| Date of filing the European patent application | 2015-06-29 | |
| (97) | Date of publication of the European application | 2017-05-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2015/051894 |
| Date | 2015-06-29 |
| (87) | Number | WO 2015/198078 |
| Date | 2015-12-30 |
| (30) | Number | Date | Country code |
| 201411496 | 2014-06-27 | GB |
| (72) |
STOTT, Colin, GB
JONES, Nick, GB
WHALLEY, Benjamin, GB
STEPHENS, Gary, GB
WILLIAMS, Claire, GB
|
| (73) |
GW Research Limited,
Sovereign House, Vision Park Histon, Cambridge, CB24 9BZ,
GB
|
| (54) | 7-HYDROXY-CANNABIDIVARIN (7-OH-CBDV) FOR USE IN THE TREATMENT OF EPILEPSY |
| 7-HYDROXY-CANNABIDIVARIN (7-OH-CBDV) FOR USE IN THE TREATMENT OF EPILEPSY |